Metraipolis › archive › dc_9b8d324ef208
Pyrroloquinoline Quinone and NAD+ Metabolism in Glaucoma: A Molecular Rationale for Combined Neuroprotection — Europe PMC PMID:42653764
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42653764
- DOI
- 10.3390/ph19081268
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T21:41:36.343Z
- SHA-256 of the archived text
eb01528a01c2d59fb5f9e77026157b07f4f0798650053a9138ccd6de5932e4db- Stable URL of this page
https://metraipolis.com/documento/dc_9b8d324ef208
How to cite
Pyrroloquinoline Quinone and NAD+ Metabolism in Glaucoma: A Molecular Rationale for Combined Neuroprotection — Europe PMC PMID:42653764 — Europe PMC (en), https://europepmc.org/article/MED/42653764 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b8d324ef208 (Metraipolis archive dc_9b8d324ef208, sha256 eb01528a01c2d59fb5f9e77026157b07f4f0798650053a9138ccd6de5932e4db)
BibTeX
@misc{dc9b8d324ef208,
title = {Pyrroloquinoline Quinone and NAD+ Metabolism in Glaucoma: A Molecular Rationale for Combined Neuroprotection — Europe PMC PMID:42653764},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42653764},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b8d324ef208; sha256 eb01528a01c2d59fb5f9e77026157b07f4f0798650053a9138ccd6de5932e4db},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42653764. Agents can read the archived copy with the MCP tool read_document.